Post Profile






Discovery’s Edge: Hope for patients with a genetic neurological disease

Life with an inherited disease sometimes brings unexpected twists and turns. Five-year-old Gus Erickson has navigated the gyrations with the help of Mayo Clinic’s Neurofibromatosis Clinic. Neurofibromatosis (NF) is a genetic disorder that causes tumors to form on nerve tissue. Those tumors can develop anywhere in the nervous system, including the brain, spinal cord and […]
read more

share

Related Posts


Mayo Clinic Neurologists Present Research at American Academy of Neurology Annual Meeting

Health : Mayo Clinic News Blog

SAN DIEGO — Mayo Clinic neurology experts will present research findings on Parkinson’s disease, Alzheimer’s disease, sleep disorders, concussions, multiple sclerosis and more at the American Academy of Neurology annual meeting in S...

Navigating Life with Parkinson Disease: New Book by American Academy of Neurology Helps Patients and Families

Health : Newswise Medical News

Published in conjunction with the American Academy of Neurology as part of the Neurology Now Books(tm) series, NAVIGATING LIFE WITH PARKINSON DISEASE, contains the most up-to-date information on this disease, providing a helpful gui...

Better Clinical Management Improves Quality of Life for Neurofibromatosis Patients

Health : Newswise Medical News

A genetic disorder called neurofibromatosis (NF) causes benign tumors to grow on the brain, spinal cord, and other parts of the nervous system. There are no effective drugs to prevent or reverse NF.

Discovery’s Edge: Using regenerative medicine to heal open wounds

Health : Mayo Clinic News Blog

New research at Mayo Clinic is bringing hope to hundreds of thousands of Crohn’s disease patients. Their extreme pain from complications is both physical and emotional and, for many, incurable. But, an innovation using the patient’s...

PTC Therapeutics Initiates Phase 2 Clinical Trial Of PTC299 In Patients With Neurofibromatosis Type 2

Health : Medical News Today

PTC Therapeutics, Inc. (PTC) announced the initiation of a Phase 2 clinical trial of PTC299 in adult patients with neurofibromatosis type 2 (NF2), a rare genetic disorder that causes the development of non-malignant brain tumors. PT...

Comments


Copyright © 2016 Regator, LLC